# FDA Inspection 1309210 - Mitchell Horwitz, M.D. - March 12, 2026

Source: https://www.keypedia.com/records/fda_inspections/mitchell-horwitz-md/e8a75aa3-671d-4456-9c64-324e81d91f88
Source feed: FDA_Inspections

> FDA Inspection 1309210 for Mitchell Horwitz, M.D. on March 12, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1309210
- Company Name: Mitchell Horwitz, M.D.
- Inspection Date: 2026-03-12
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics

## Related Documents

- [FDA Inspection 1309210 - 2026-03-12](https://www.keypedia.com/records/fda_inspections/mitchell-horwitz-md/0637a973-f02f-4406-a025-6f2c3b9c6870)
- [FDA Inspection 1177854 - 2022-08-19](https://www.keypedia.com/records/fda_inspections/mitchell-horwitz-md/9c6ae860-50a6-44e0-b0f2-ecab949fd205)

Company: https://www.keypedia.com/companies/mitchell-horwitz-md/e1c48c75-5581-4a10-b78c-11bcbc17ab53